Laserfiche WebLink
DocuSign Envelope ID: A17787FA-E2E4-465E-9081-70753D6210B5 <br />4&A/\ON <br />Axon Enterprise, Inc.'s TASER 7 <br />Agreement <br />to Evidence.com or any third party, (ii) may adversely impact Evidence.com or the <br />systems or content of any other customer, (iii) may subject Axon, Axon's affiliates, or <br />any third party to liability, or (iv) may be fraudulent; <br />Agency remains responsible for all fees and charges incurred through the date of suspension <br />without any credits for any period of suspension. Axon will not delete any of Agency Content <br />on Evidence.com due to suspension, except as specified elsewhere in this Agreement. <br />11 Evidence.com Warranty. Axon warrants that Evidence.com will not infringe or <br />misappropriate any patent, copyright, trademark, or trade secret rights of any third party. <br />Axon disclaims any warranties or responsibility for data corruption or errors before the data <br />is uploaded to Evidence.com. <br />12 Evidence.com Restrictions. All Evidence.com subscriptions will immediately terminate if <br />Agency does not comply with any term of this Agreement. Agency and Agency end users <br />(including employees, contractors, agents, officers, volunteers, and directors), may not, or may <br />not attempt to: <br />12.1. copy, modify, tamper with, repair, or create derivative works of any part of <br />Evidence.com; <br />12.2. reverse engineer, disassemble, or decompile Evidence.com or apply any other process <br />to derive any source code included in Evidence.com, or allow any others to do the <br />same; <br />12.3. access or use Evidence.com with the intent to gain unauthorized access, avoid <br />incurring fees or exceeding usage limits or quotas; <br />12.4. use trade secret information contained in Evidence.com, except as expressly <br />permitted in this Agreement; <br />12.5. access Evidence.com to build a competitive product or service or copy any features, <br />functions, or graphics of Evidence.com; <br />12.6. remove, alter, or obscure any confidentiality or proprietary rights notices (including <br />copyright and trademark notices) of Axon's or Axon's licensors on or within <br />Evidence.com ; or <br />12.7. use Evidence.com to store or transmit infringing, libelous, or otherwise unlawful or <br />tortious material, to store ortransmit material in violation of third party privacy rights, <br />or to store or transmit malicious code. <br />13 After Termination. Axon will not delete Agency Content for 90 days following termination. <br />During this 90-day period, Agency may retrieve Agency Content only if all amounts due have <br />been paid. There will be no application functionality of Evidence.com during this 90-day period <br />other than the ability to retrieve Agency Content. Agency will not incur any additional fees if <br />Agency Content is downloaded from Evidence.com during this 90-day period. Axon has no <br />obligation to maintain or provide any Agency Content after this 90-day period and will <br />thereafter, unless legally prohibited delete all of Agency Contentstored in Evidence.com. Upon <br />request, Axon will provide written proof that all Agency Content has been successfully deleted <br />and fully removed from Evidence.com. <br />14 Post -Termination Assistance. Axon will provide Agency with the same post -termination data <br />n.: TASER7A ..:...t <br />ver.i..: to <br />Wl.—O.: ta29201e <br />Page 6 of 7 <br />25H-12 <br />